Patents by Inventor Indu Muni

Indu Muni has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240075045
    Abstract: Compositions and methods of treating pericarditis and preventing recurrent pericarditis are provided.
    Type: Application
    Filed: December 14, 2021
    Publication date: March 7, 2024
    Inventors: Indu MUNI, Neal MUNI, Naomi VISHNUPAD
  • Publication number: 20230355588
    Abstract: Liquid oral pilocarpine formulations are described herein. Methods of using the liquid oral pilocarpine formulations are also provided.
    Type: Application
    Filed: December 8, 2022
    Publication date: November 9, 2023
    Inventors: Indu MUNI, Naomi VISHNUPAD
  • Publication number: 20230330016
    Abstract: The use of oral colchicine solutions in combination with other therapeutics, while minimizing toxic drug to drug interactions are described herein. Related compositions are also provided.
    Type: Application
    Filed: April 28, 2023
    Publication date: October 19, 2023
    Applicant: RxOMEG Therapeutics LLC
    Inventors: Indu Muni, Naomi Vishnupad
  • Publication number: 20230301907
    Abstract: The invention relates to stable vancomycin hydrochloride powder for oral liquid formulations. Also provided herein are methods of using vancomycin oral liquid formulations for the treatment of certain diseases such as Clostridium difficile pseudomembranous colitis and Staphylococcal enterocolitis as well as kits and related products thereof.
    Type: Application
    Filed: September 28, 2022
    Publication date: September 28, 2023
    Applicant: Azurity Pharmaceuticals, Inc.
    Inventors: Indu Muni, Peter Mione, Anisa Gandhi, Cristina LeChiara
  • Patent number: 11672759
    Abstract: The use of oral colchicine solutions in combination with other therapeutics, while minimizing toxic drug to drug interactions are described herein. Related compositions are also provided.
    Type: Grant
    Filed: August 19, 2019
    Date of Patent: June 13, 2023
    Assignee: RxOMEG Therapeutics LLC
    Inventors: Indu Muni, Naomi Vishnupad
  • Patent number: 11638692
    Abstract: The invention relates to stable vancomycin hydrochloride powder for oral liquid formulations. Also provided herein are methods of using vancomycin oral liquid formulations for the treatment of certain diseases such as Clostridium difficile pseudomembranous colitis and Staphylococcal enterocolitis as well as kits and related products thereof.
    Type: Grant
    Filed: October 13, 2022
    Date of Patent: May 2, 2023
    Assignee: Azurity Pharmaceuticals, Inc.
    Inventors: Indu Muni, Peter Mione, Anisa Gandhi, Cristina LeChiara
  • Publication number: 20230102830
    Abstract: The invention relates to stable vancomycin hydrochloride powder for oral liquid formulations. Also provided herein are methods of using vancomycin oral liquid formulations for the treatment of certain diseases such as Clostridium difficile pseudomembranous colitis and Staphylococcal enterocolitis as well as kits and related products thereof.
    Type: Application
    Filed: October 13, 2022
    Publication date: March 30, 2023
    Applicant: Azurity Pharmaceuticals, Inc.
    Inventors: Indu Muni, Peter Mione, Anisa Gandhi, Cristina LeChiara
  • Patent number: 11564909
    Abstract: Liquid oral pilocarpine formulations are described herein. Methods of using the liquid oral pilocarpine formulations are also provided.
    Type: Grant
    Filed: November 29, 2021
    Date of Patent: January 31, 2023
    Assignee: ROMEG Therapeutics LLC
    Inventors: Indu Muni, Naomi Vishnupad
  • Publication number: 20220175733
    Abstract: Liquid oral pilocarpine formulations are described herein. Methods of using the liquid oral pilocarpine formulations are also provided.
    Type: Application
    Filed: November 29, 2021
    Publication date: June 9, 2022
    Inventors: Indu MUNI, Naomi VISHNUPAD
  • Publication number: 20210169799
    Abstract: The invention relates to stable vancomycin hydrochloride powder for oral liquid formulations. Also provided herein are methods of using vancomycin oral liquid formulations for the treatment of certain diseases such as Clostridium difficile pseudomembranous colitis and Staphylococcal enterocolitis as well as kits and related products thereof.
    Type: Application
    Filed: February 2, 2021
    Publication date: June 10, 2021
    Applicant: Azurity Pharmaceuticals, Inc.
    Inventors: Indu Muni, Peter Mione, Anisa Gandhi, Cristina LeChiara
  • Patent number: 10959946
    Abstract: The invention relates to stable vancomycin hydrochloride powder for oral liquid formulations. Also provided herein are methods of using vancomycin oral liquid formulations for the treatment of certain diseases such as Clostridium difficile pseudomembranous colitis and Staphylococcal enterocolitis as well as kits and related products thereof.
    Type: Grant
    Filed: March 13, 2015
    Date of Patent: March 30, 2021
    Assignee: Azurity Pharmaceuticals, Inc.
    Inventors: Indu Muni, Peter Mione, Anisa Gandhi, Cristina LeChiara
  • Patent number: 10959947
    Abstract: The invention relates to stable vancomycin hydrochloride powder for oral liquid formulations. Also provided herein are methods of using vancomycin oral liquid formulations for the treatment of certain diseases such as Clostridium difficile pseudomembranous colitis and Staphylococcal enterocolitis as well as kits and related products thereof.
    Type: Grant
    Filed: June 4, 2020
    Date of Patent: March 30, 2021
    Assignee: Azurity Pharmaceuticals, Inc.
    Inventors: Indu Muni, Peter Mione, Anisa Gandhi, Cristina LeChiara
  • Patent number: 10959949
    Abstract: The invention relates to stable vancomycin hydrochloride powder for oral liquid formulations. Also provided herein are methods of using vancomycin oral liquid formulations for the treatment of certain diseases such as Clostridium difficile pseudomembranous colitis and Staphylococcal enterocolitis as well as kits and related products thereof.
    Type: Grant
    Filed: July 28, 2020
    Date of Patent: March 30, 2021
    Assignee: Azurity Pharmaceuticals, Inc.
    Inventors: Indu Muni, Peter Mione, Anisa Gandhi, Cristina LeChiara
  • Patent number: 10959948
    Abstract: The invention relates to stable vancomycin hydrochloride powder for oral liquid formulations. Also provided herein are methods of using vancomycin oral liquid formulations for the treatment of certain diseases such as Clostridium difficile pseudomembranous colitis and Staphylococcal enterocolitis as well as kits and related products thereof.
    Type: Grant
    Filed: July 28, 2020
    Date of Patent: March 30, 2021
    Assignee: Azurity Pharmaceuticals, Inc.
    Inventors: Indu Muni, Peter Mione, Anisa Gandhi, Cristina LeChiara
  • Publication number: 20210038515
    Abstract: The invention relates to stable vancomycin hydrochloride powder for oral liquid formulations. Also provided herein are methods of using vancomycin oral liquid formulations for the treatment of certain diseases such as Clostridium difficile pseudomembranous colitis and Staphylococcal enterocolitis as well as kits and related products thereof.
    Type: Application
    Filed: October 22, 2020
    Publication date: February 11, 2021
    Applicant: Azurity Pharmaceuticals, Inc.
    Inventors: Indu Muni, Peter Mione, Anisa Gandhi, Cristina LeChiara
  • Publication number: 20210023002
    Abstract: The invention relates to stable vancomycin hydrochloride powder for oral liquid formulations. Also provided herein are methods of using vancomycin oral liquid formulations for the treatment of certain diseases such as Clostridium difficile pseudomembranous colitis and Staphylococcal enterocolitis as well as kits and related products thereof.
    Type: Application
    Filed: August 7, 2020
    Publication date: January 28, 2021
    Applicant: Azurity Pharmaceuticals, Inc.
    Inventors: Indu Muni, Peter Mione, Anisa Gandhi, Cristina LeChiara
  • Publication number: 20200360283
    Abstract: The invention relates to stable vancomycin hydrochloride powder for oral liquid formulations. Also provided herein are methods of using vancomycin oral liquid formulations for the treatment of certain diseases such as Clostridium difficile pseudomembranous colitis and Staphylococcal enterocolitis as well as kits and related products thereof.
    Type: Application
    Filed: July 28, 2020
    Publication date: November 19, 2020
    Applicant: Azurity Pharmaceuticals, Inc.
    Inventors: Indu Muni, Peter Mione, Anisa Gandhi, Cristina LeChiara
  • Publication number: 20200352858
    Abstract: The invention relates to stable vancomycin hydrochloride powder for oral liquid formulations. Also provided herein are methods of using vancomycin oral liquid formulations for the treatment of certain diseases such as Clostridium difficile pseudomembranous colitis and Staphylococcal enterocolitis as well as kits and related products thereof.
    Type: Application
    Filed: July 28, 2020
    Publication date: November 12, 2020
    Applicant: Azurity Pharmaceuticals, Inc.
    Inventors: Indu Muni, Peter Mione, Anisa Gandhi, Cristina LeChiara
  • Publication number: 20200306186
    Abstract: The invention relates to stable vancomycin hydrochloride powder for oral liquid formulations. Also provided herein are methods of using vancomycin oral liquid formulations for the treatment of certain diseases such as Clostridium difficile pseudomembranous colitis and Staphylococcal enterocolitis as well as kits and related products thereof.
    Type: Application
    Filed: June 4, 2020
    Publication date: October 1, 2020
    Applicant: Azurity Pharmaceuticals, Inc.
    Inventors: Indu Muni, Peter Mione, Anisa Gandhi, Cristina LeChiara
  • Patent number: 10688046
    Abstract: The invention relates to stable vancomycin hydrochloride powder for oral liquid formulations. Also provided herein are methods of using vancomycin oral liquid formulations for the treatment of certain diseases such as Clostridium difficile pseudomembranous colitis and Staphylococcal enterocolitis as well as kits and related products thereof.
    Type: Grant
    Filed: November 6, 2019
    Date of Patent: June 23, 2020
    Assignee: CutisPharma, Inc.
    Inventors: Indu Muni, Peter Mione, Anisa Gandhi, Cristina LeChiara